ArticleScientific reports2026
Plasma-aqueous dual-fluid NEAT1/miR-93-5p axis may be involved in retinal ganglion cell degeneration in glaucoma: mechanistic dissection and diagnostic model construction.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The progressive degeneration of retinal ganglion cells (RGCs) is the primary pathological characteristic of glaucoma. The role of the NEAT1/miR-93-5p axis, a crucial part of the ceRNA network, in the plasma-aqueous dual-fluid of glaucoma and its regulatory mechanism for RGC degeneration remain unclear. Patients with glaucoma and those with simple cataracts had their plasma and aqueous humor (AH) samples taken. The expressions of NEAT1 and miR-93-5p were detected by qRT-PCR. The Pearson correlation analysis method was used to examine the expression correlation in the plasma-aqueous dual-fluid. Logistic regression analysis was used to identify independent factors associated with the disease state. To investigate the regulatory effects of the NEAT1/miR-93-5p axis on cell viability, inflammatory response, and oxidative stress, a NaIO₃-induced cell damage model was built. In comparison to the control group, glaucoma patients had significantly higher levels of NEAT1 in their plasma and AH, significantly lower levels of miR-93-5p, and a negative correlation between NEAT1 and miR-93-5p. NEAT1 and miR-93-5p are independent factors related to the pathological state of glaucoma. According to cell experiments, high NEAT1 expression would inhibit cell viability, promotes the release of inflammatory factors. Silencing NEAT1 can reverse this damage, and this regulatory effect may be mediated by miR-93-5p. The NEAT1/miR-93-5p axis in plasma may potentially serve as a biomarker for the diagnosis of glaucoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.